Author:
Takahashi Kohei,Nakagawasai Osamu,Nemoto Wataru,Nakajima Takeharu,Arai Yuichiro,Hisamitsu Tadashi,Tan-No Koichi
Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. Baik JH, Picetti R, Saiardi A, Thiriet G, Dierich A, Depaulis A, Le Meur M, Borrelli E (1995) Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377:424–8
2. Bamford NS, Robinson S, Palmiter RD, Joyce JA, Moore C, Meshul CK (2004) Dopamine modulates release from corticostriatal terminals. J Neurosci 24:9541–52
3. Balsara JJ, Nandal NV, Mane VR, Chandorkar AG (1982) Experimental evaluation of the antidepressant and neuroleptic activity of maprotiline. Indian J Physiol Pharmacol 26:183–95
4. Boger HA, Middaugh LD, Patrick KS, Ramamoorthy S, Denehy ED, Zhu H, Pacchioni AM, Granholm AC, McGinty JF (2007) Long-term consequences of methamphetamine exposure in young adults are exacerbated in glial cell line-derived neurotrophic factor heterozygous mice. J Neurosci 27:8816–25
5. Breuer ME, Groenink L, Oosting RS, Buerger E, Korte M, Ferger B, Olivier B (2009a) Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats. Eur J Pharmacol 616:134–40